HemaSphere (Apr 2022)

P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”

  • G Mele,
  • N Cascavilla,
  • N Di Renzo,
  • A Guarini,
  • P Mazza,
  • L Melillo,
  • V Pavone,
  • G Tarantini,
  • P Curci,
  • AP Falcone,
  • C Germano,
  • A Mele,
  • G Palazzo,
  • G Palumbo,
  • G Reddiconto,
  • B Rossini,
  • G Specchia,
  • P Musto,
  • D Pastore

DOI
https://doi.org/10.1097/01.HS9.0000829640.69738.dc
Journal volume & issue
Vol. 6
pp. 20 – 21

Abstract

Read online

No abstracts available.